naltrexone has been researched along with Hibernation, Myocardial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolli, R; Kodani, E; Shinmura, K; Takano, H; Tang, XL; Xuan, YT | 1 |
Fobker, M; Grosse Hartlage, MA; Monteiro de Oliveira, NP; Theisen, MM; Van Aken, H; Weber, TP | 1 |
2 other study(ies) available for naltrexone and Hibernation, Myocardial
Article | Year |
---|---|
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Benzylidene Compounds; Celecoxib; Consciousness; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Heart Rate; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Myocardial Infarction; Myocardial Stunning; Myocardium; Naltrexone; Narcotic Antagonists; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Opioid, delta; Sulfonamides | 2002 |
Kappa-opioid receptor antagonism improves recovery from myocardial stunning in chronically instrumented dogs.
Topics: Animals; beta-Endorphin; Blood Pressure; Coronary Circulation; Dogs; Dynorphins; Epinephrine; Female; Heart Rate; Male; Myocardial Stunning; Naltrexone; Narcotic Antagonists; Norepinephrine; Radioimmunoassay; Receptors, Opioid, kappa; Ventricular Function, Left | 2006 |